Clinical trial
Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin…
NCT00065117 · AstraZeneca, Industry · Terminated
Key facts
| NCT number | NCT00065117 |
|---|---|
| Title | Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer. |
| Lead sponsor | AstraZeneca, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Neoplasms, Metastases, Neoplasm |
| Intervention type | Drug |
| Interventions | ZD6126, Placebo, 5-fluorouracil, leucovorin, oxaliplatin |
| Enrollment | 180 |
| Start date | Sep 1, 2003 |
| Primary completion | Feb 1, 2004 |
| Completion | Feb 1, 2004 |
| First posted | Jul 18, 2003 |
| Last update posted | Jan 26, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: